Search results
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
InvestorPlace· 1 day agoSarepta Therapeutics (NASDAQ:SRPT) stock jumped about 30% overnight after the Food and Drug...
Stocks to Watch Friday: Nvidia, Micron, Sarepta, CarMax
The Wall Street Journal· 1 day ago**Sarepta Therapeutics (SRPT)**: Shares in the biotechnology company rocketed around 35% after the...
Sarepta Therapeutics, Ryan Specialty rise; Autodesk, Trump Media fall, Friday, 6/21/2024
Associated Press· 1 day agoStocks that traded heavily or had substantial price changes on Friday: Sarepta Therapeutics, Ryan Specialty rise; Autodesk, Trump Media fall
Sarepta Therapeutics Soars on Expanded Approval for Its Muscular Dystrophy Drug
Investopedia via Yahoo Finance· 1 day agoSarepta Therapeutics shares jumped in premarket trading Friday, a day after the biotech firm...
Sarepta Therapeutics surges 32% on expanded FDA approval for Duchenne gene therapy
Investing.com via Yahoo Finance· 1 day agoInvesting.com - Sarepta Therapeutics (NASDAQ:SRPT), a pioneer in precision genetic medicine for rare diseases, surged sharply following the market open ...
Sarepta surges as investors cheer expanded use of gene therapy
WSAU Wausau· 1 day ago(Reuters) - Sarepta Therapeutics shares surged about 36% in premarket trading on Friday as an expanded use approval opened up a bigger market in the U.S ...
Sarepta stock soars on Duchenne gene therapy expanded approval - Boston Business Journal
The Business Journals· 1 day agoShares of Sarepta Therapeutics shot up nearly 35% when markets opened Friday, following the FDA's...
Sarepta Therapeutics Surges on FDA Approval for Expanded ELEVIDY
Guru Focus· 1 day agoSarepta Therapeutics (SRPT) saw a 36% surge after the FDA approved an expanded indication for ELEVIDYS. The label now includes individuals with Duchenne muscula
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
CNBC· 1 day agoShares of the biopharma company surged 30% after the U.S. Food and Drug Administration approved the...
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
CNBC· 1 day agoThe decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most valuable...